ArticleCureus2026
Post-IVIG Aseptic Meningitis in a Pediatric Patient With Kawasaki Disease: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intravenous immunoglobulin (IVIG)-induced aseptic meningitis is a rare but well-recognized neurological complication that may closely mimic bacterial meningitis, making diagnosis challenging. Prompt recognition is essential to avoid unnecessary antimicrobial therapy and prolonged hospitalization. We report the case of a previously healthy 12-year-old boy who developed aseptic meningitis seven days after receiving high-dose IVIG for Kawasaki disease (KD). He presented with severe headache, vomiting, fever, and mild neck stiffness. Cerebrospinal fluid (CSF) analysis demonstrated neutrophilic pleocytosis (248 cells/mm³, 80% neutrophils) with negative Gram stain and bacterial cultures. Following the exclusion of infectious causes, the patient recovered completely with supportive care alone. This case highlights that IVIG-induced aseptic meningitis may occur later than the commonly reported 24-72 hours after infusion. Awareness of this uncommon but benign adverse event, together with careful interpretation of CSF findings and exclusion of infectious meningitis, is essential to ensure appropriate management, avoid unnecessary investigations and antibiotic therapy, and reassure clinicians and families regarding its excellent prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.